Transjugular Intrahepatic Portosystemic Shunts in Patients with Hepatic Malignancy

ABSTRACT

Since its first clinical application in 1988, the transjugular intrahepatic portosystemic shunt (TIPS) has emerged as a safe and effective means of managing patients with morbid portal hypertension. Despite the considerable body of literature on TIPS, portal decompression in patients with malignancy has not been sufficiently examined. These patients typically experience sequelae of portal hypertension that requires palliation. The purpose of this article is to review the reported experience with TIPS in patients with malignancy.

KEYWORDS

Hepatic neoplasm - interventional procedure - portosystemic shunt - portal hypertension

REFERENCES

• 1 Cello J P, Ring E J, Olcott E W et al.. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized, controlled trial.  Ann Intern Med. 1997;  126 858-865
• 2 Rossle M, Deibert P, Haag K et al.. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.  Lancet. 1997;  349 1043-1049
• 3 Pomier-Layrargues G, Villeneuve J P, Deschenes M et al.. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.  Gut. 2001;  48 390-396
• 4 Rossle M, Ochs A, Gulberg V et al.. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.  N Engl J Med. 2000;  342 1701-1707
• 5 Gordon F D, Anastopoulos H T, Crenshaw W et al.. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.  Hepatology. 1997;  25 1366-1369
• 6 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum H E, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.  Eur J Gastroenterol Hepatol. 2001;  13 529-534
• 7 Perello A, Garcia-Pagan J C, Gilabert R et al.. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.  Hepatology. 2002;  35 132-139
• 8 Blum U, Rossle M, Haag K et al.. Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt.  Radiology. 1995;  197 805-811
• 9 Haskal Z J, Martin L, Cardella J F et al.. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of Practice Committee.  J Vasc Interv Radiol. 2001;  12 131-136
• 10 Nakamura K, Hamuro M, Nishida N, Kaminou T, Satoh K, Matsuoka T. Hepatocellular Carcinoma and Portal Hypertension: Indication for Transjugular Intrahepatic Portosystemic Shunt. Chicago, IL; Radiological Society of North America 2002
• 11 Sakaguchi H, Uchida H, Maeda M et al.. Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report.  Cardiovasc Intervent Radiol. 1995;  18 9-15
• 12 Wallace M J, Madoff D C, Ahrar K, Warneke C L. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.  Cancer. 2004;  101 337-345
• 13 Azoulay D, Buabse F, Damiano I et al.. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension.  J Am Coll Surg. 2001;  193 46-51
• 14 Zuckerman D A, Darcy M D, Bocchini T P, Hildebolt C F. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors.  AJR Am J Roentgenol. 1997;  169 1727-1731
• 15 LaBerge J M, Ring E J, Gordon R L et al.. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients.  Radiology. 1993;  187 413-420
• 16 Hidajat N, Vogl T, Stobbe H et al.. Transjugular intrahepatic portosystemic shunt: experiences at a liver transplantation center.  Acta Radiol. 2000;  41 474-478
• 17 Malinchoc M, Kamath P S, Gordon F D, Peine C J, Rank J, ter Borg P C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.  Hepatology. 2000;  31 864-871
• 18 Barton R E, Rosch J, Saxon R R, Lakin P C, Petersen B D, Keller F S. TIPS-short and long-term results: a survey of 1750 patients.  Semin Intervent Radiol. 1995;  12 364-367
• 19 Jiang Z B, Shan H, Shen X Y et al.. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.  World J Gastroenterol. 2004;  10 1881-1884
• 20 Otal P, Smayra T, Bureau C et al.. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures.  AJR Am J Roentgenol. 2002;  178 141-147
• 21 Hur J, Lee K H, Lee J H, Yu J S, Won J Y, Lee D Y. Stent-graft for TIPS in a hepatocellular carcinoma patient with main portal vein invasion.  AJR Am J Roentgenol. 2004;  182 1301-1304
• 22 Petersen B. Intravascular ultrasound-guided direct intrahepatic portacaval shunt: description of technique and technical refinements.  J Vasc Interv Radiol. 2003;  14 21-32
• 23 Soares G M, Murphy T P. Transcaval TIPS: indications and anatomic considerations.  J Vasc Interv Radiol. 1999;  10 1233-1238
• 24 Walser E M, NcNees S W, DeLa Pena O et al.. Portal venous thrombosis: percutaneous therapy and outcome.  J Vasc Interv Radiol. 1998;  9 119-127
• 25 Radosevich P M, Ring E J, LaBerge J M et al.. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion.  Radiology. 1993;  186 523-527
• 26 Matsui O, Yoshikawa J, Kadoya M et al.. Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach.  Cardiovasc Intervent Radiol. 1996;  19 352-355
• 27 Yamagami T, Nakamura T, Tanaka O, Akada W, Takayama T, Maeda T. Transjugular intrahepatic portosystemic shunt after complete obstruction of portal vein.  J Vasc Interv Radiol. 1999;  10 575-578
• 28 Jalan R, Lui H F, Redhead D N, Hayes P C. TIPSS 10 years on.  Gut. 2000;  46 578-581
• 29 Saxon R S, Ross P L, Mendel-Hartvig J et al.. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms.  Radiology. 1998;  207 683-693
• 30 Wallace M, Swaim M. Transjugular intrahepatic portosystemic shunts through hepatic neoplasms.  J Vasc Interv Radiol. 2003;  14 501-507
• 31 Saxon R R, Mendel-Hartvig J, Corless C L et al.. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine.  J Vasc Interv Radiol. 1996;  7 487-497
• 32 Hausegger K A, Karnel F, Georgieva B et al.. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.  J Vasc Interv Radiol. 2004;  15 239-248
• 33 Encarnacion C E, Palmaz J C, Rivera F J et al.. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality.  J Vasc Interv Radiol. 1995;  6 687-694
• 34 Coldwell D M, Ring E J, Rees C R et al.. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension.  Radiology. 1995;  196 335-340
• 35 Gines P, Uriz J, Calahorra B et al.. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.  Gastroenterology. 2002;  123 1839-1847
• 36 Ferral H, Vasan R, Speeg K V et al.. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures.  J Vasc Interv Radiol. 2002;  13 1103-1108
• 37 Angermayr B, Cejna M, Karnel F et al.. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.  Gut. 2003;  52 879-885